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Abstract: In the last decade, we witnessed discoveries that established Zn2+ as a second major
signalling metal ion in the transmission of information within cells and in communication between
cells. Together with Ca2+ and Mg2+, Zn2+ covers biological regulation with redox-inert metal ions
over many orders of magnitude in concentrations. The regulatory functions of zinc ions, together
with their functions as a cofactor in about three thousand zinc metalloproteins, impact virtually all
aspects of cell biology. This article attempts to define the regulatory functions of zinc ions, and focuses
on the nature of zinc signals and zinc signalling in pathways where zinc ions are either extracellular
stimuli or intracellular messengers. These pathways interact with Ca2+, redox, and phosphorylation
signalling. The regulatory functions of zinc require a complex system of precise homeostatic control
for transients, subcellular distribution and traffic, organellar homeostasis, and vesicular storage and
exocytosis of zinc ions.
Keywords: zinc; homeostasis; signalling; regulation
1. Zinc in Enzymatic Catalysis, Protein Structure, and Regulation of Proteins
It is ingrained in our understanding of the scientific literature that zinc has catalytic, structural,
and regulatory functions in proteins. However, while the first two functions are well-established,
validated examples of regulatory molecular functions are much more difficult to pinpoint. Catalytic and
structural functions occur in an estimated 3000 human zinc metalloproteins, a number that translates
into about every tenth protein being a zinc protein [1]. This myriad of functions demonstrates the
major role of zinc in cell biology [2], which is now reinforced by the emerging roles of zinc ions in
cellular regulation [3]. Many earlier postulates about regulatory functions of zinc in proteins are
based on outdated premises, were not linked to specific molecular actions in physiological events,
and involved zinc/protein interactions that occur with micromolar affinities. Compelling arguments
put such interactions outside the physiological range of cellular zinc ion concentrations. They are based
on experimental results and the requirement to control zinc in a range of concentrations that avoids
interference with the biochemistry of the other essential metal ions. Measurements of zinc binding
constants of zinc proteins, and total and available (“free”) zinc concentrations now provide a different
view of the physiological significance of zinc/protein interactions. Affinities of structural and catalytic
zinc in cellular proteins are in the picomolar to femtomolar range, and at present, evidence is lacking
that these sites are regulated via zinc binding and release [4,5]. As a consequence of this high affinity,
the “free” zinc ion concentration is in the picomolar range, as shown experimentally, despite the total
cellular zinc concentration being in the range of hundreds of micromolar [6]. This large difference
between total and “free” zinc is a distinctive chemical property of zinc in biology [7]. It rules out low
affinity zinc binding sites as being physiologically significant for cellular regulation, and suggests that
regulatory sites of zinc in cellular proteins must have binding constants commensurate with these
Int. J. Mol. Sci. 2017, 18, 2285; doi:10.3390/ijms18112285 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2017, 18, 2285 2 of 12
chemical and biological constraints. In fact, a couple of examples of zinc inhibiting enzymes with
picomolar affinity are now known [8–10]. Also, it was reported about 50 years ago that picomolar
concentrations of zinc (II) ions inhibit phosphoglucomutase by replacing the magnesium ion required
for activity [11]. The authors discussed the physiological significance of the finding, but their reports
received very little, if any recognition in the field of metallobiochemistry [12]. In terms of its rather
high affinity for binding sites, Zn2+ is different from Mg2+ and Ca2+, and makes an additional range
available for biological regulation using all three redox-inert metal ions (Figure 1). What is needed for
regulation is a change in the concentration of “free” zinc ions (zinc transients). This article discusses
how such changes can be effected, and controlled, in a zinc-buffered biological environment. In the
cell, zinc transients occur from a basal level of tens to hundreds of pM free zinc (about 0.2 mM total
cellular zinc). They leave a gap of three orders of magnitude before calcium transients can set in,
which are above a basal level of 100 nM free calcium (about 2 mM total cellular calcium). Like calcium,
zinc needs a system to control these transients, and is cytotoxic if not properly controlled. Regarding
magnesium, recently described circadian rhythms of total magnesium concentrations in cells provide
strong evidence for regulatory functions [13].
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Figure 1. Biological regulation with the three redox-inert metals ions: Mg2+, Ca2+, and Zn2+. Zinc 
extends the range of regulation with metal ions. The regulatory function of each metal ion is in a 
specific range of concentrations, thus avoiding overlap with the signalling functions of the other 
metal ions. However, there are interactions among the metabolism of the metal ions. 
2. Control of Cellular Zinc Homeostasis 
Knowledge about the proteins that control cellular zinc now provides a basis for understanding 
how zinc ions can regulate cellular processes. In humans, at least twenty-four membrane 
transporters (14 Zrt, Irt-like proteins (ZIP) zinc importers and 10 zinc transporters (ZnT) zinc 
exporters), about a dozen metallothioneins (MTs), and a zinc-sensing transcription factor, 
metal-response element (MRE)-binding transcription factor-1 (MTF-1), are involved in controlling 
cellular zinc [14]. A few of these transporters have a role—or an additional role—in Mn2+ and Fe2+ 
transport, while MT also has a function in copper metabolism [15]. The number of membrane 
transporters is much higher than what one would expect for simple control of homeostasis of a 
metabolite. Cellular iron, for example, is essentially controlled by one importer (DMT1) and one 
exporter protein (ferroportin). It turned out that many additional transporter proteins are necessary 
for the subcellular distribution of zinc, the control of organellar zinc homeostasis, and the generation 
and control of zinc transients. Most of the ZIP transporters have been found on the plasma 
membrane, but some have roles intracellularly. The large number of ZIP transporters on the plasma 
membrane is likely a reflection of the importance of securing the correct supply of zinc for the cell 
under various conditions. Remarkably, zinc ions accumulate in cellular vesicles for storage and/or 
release, and in secretory vesicles for exocytosis. The occurrence of zinc ions in cellular vesicles is a 
characteristic feature of cellular zinc biology, and resolves the long-standing issue why a storage 
protein akin to ferritin, which stores several thousand iron ions in its core, was never found for zinc. 
There is some ambiguity in the nature of some of these vesicles. Vesicular stores that accumulate 
zinc added to cultured cells have been called zincosomes [16]. Others are secretory vesicles from 
which zinc ions are exocytosed for various purposes. These vesicles differ from intracellular 
vesicular/organellar stores of zinc, as ZIP transporters do not seem to counteract the action of the 
ZnT transporters (ZnT2, 3, and 8) loading these vesicles with zinc ions. The “lethal milk” mouse has 
a truncated form of ZnT4, and presents with low zinc concentration in the milk and developmental 
defects of the mammary gland [17]. Zinc transporters ZnT4–7 are involved in loading zinc-requiring 
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Zinc extends the range of regulation with metal ions. The regulatory function of each metal ion
is in a specific range of concentrations, thus avoiding overlap with the signalling functions of the other
metal ions. However, there are interactions among the metabolism of the metal ions.
2. Control of Cellular Zinc Homeostasis
Knowledge about the proteins that control cellular zinc now provides a basis for understanding
how zinc ions can regulate cellular processes. In humans, at least twenty-four membrane transporters
(14 Zrt, Irt-like proteins (ZIP) zinc importers and 10 zinc transporters (ZnT) zinc exporters),
about a dozen metallothioneins (MTs), and a zinc-sensing transcription factor, metal-response element
(MRE)-binding transcription factor-1 (MTF-1), are involved in controlling cellular zinc [14]. A few of
these transporters have a role—or an additional role—in Mn2+ and Fe2+ transport, while MT also has
a function in copper metabolism [15]. The number of membrane transporters is much higher than
what one would expect for simple control of homeostasis of a metabolite. Cellular iron, for example,
is essentially controlled by one importer (DMT1) and one exporter protein (ferroportin). It turned
out that many additional transporter proteins are necessary for the subcellular distribution of zinc,
the control of organellar zinc homeostasis, and the generation and control of zinc transients. Most of
the ZIP transporters have been found on the plasma membrane, but some have roles intracellularly.
The large number of ZIP transporters on the plasma membrane is likely a reflection of the importance
of securing the correct supply of zinc for the cell under various conditions. Remarkably, zinc ions
accumulate in cellular vesicles for storage and/or release, and in secretory vesicles for exocytosis.
The occurrence of zinc ions in cellular vesicles is a characteristic feature of cellular zinc biology,
and resolves the long-standing issue why a storage protein akin to ferritin, which stores several
thousand iron ions in its core, was never found for zinc. There is some ambiguity in the nature
of some of these vesicles. Vesicular stores that accumulate zinc added to cultured cells have been
called zincosomes [16]. Others are secretory vesicles from which zinc ions are exocytosed for various
purposes. These vesicles differ from intracellular vesicular/organellar stores of zinc, as ZIP transporters
do not seem to counteract the action of the ZnT transporters (ZnT2, 3, and 8) loading these vesicles
with zinc ions. The “lethal milk” mouse has a truncated form of ZnT4, and presents with low zinc
concentration in the milk and developmental defects of the mammary gland [17]. Zinc transporters
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ZnT4–7 are involved in loading zinc-requiring ectoenzymes with zinc at the trans Golgi network
(TGN)/early secretory pathway [18]. Zinc is also translocated to lysosomes, mitochondria, and nuclei,
but very little is known about the transporters involved. Zincosomes and related vesicles require
additional components for control of zinc homeostasis in order to link cellular uptake and store loading.
Thus, there is an at least three-tiered system for the homeostatic control of cellular zinc: import and
export through the plasma membrane, including cytosolic binding proteins such as metallothioneins
and sensors such as MTF-1 (tier 1); intracellular storage and release of zinc generating zinc transients
(tier 2); and allocation of zinc for exocytosis in some cells, somehow linked to re-uptake (tier 3)
(Figure 2). It appears that a hierarchy is associated with these three tiers, namely, that the capacity
of loading vesicles is compromised, first, under zinc deficiency, as suggested by investigations with
cultured cells [19].
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Figure 2. Control f cellu ar zinc home i including regulation of zinc and functions of zinc in
regulation. (1) Tier 1: cellular homeostasis t r gh import and export through the plasma membrane
and subcellular distribution; (2) Tier 2: vesicular storage and/or release of zinc associated with zinc
importers and exporters on the vesicles; (3) Tier 3: loading of secretory vesicles with zinc associated
only with zinc exporters on the vesicles. Regulatory functions of zinc require additional complexity
in homeostatic control, namely, molecules that control the spatiotemporal fluctuations of zinc ions
in a metal-buffered environment, above the fluxes in re-distributing zinc for supply as a cofactor in
catalytic and structural sites of proteins. With this distinction, we assume that the functions of bona
fide zinc proteins are not regulated by zinc coming on and off from their catalytic and structural sites.
(Figures were composed from Servier Medical Art templates (http://smart.servier.com/)).
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There are at least three pathways for transient release of zinc ions within and from cells.
The proteins participating in the control of homeostasis (ZIPs, ZnTs, metallothioneins, and MTF-1)
restore the steady-state after the transients have occurred (Figure 3). A breakthrough that triggered the
discovery of these pathways, and the functions associated with them, came with the synthesis and
availability of fluorescent chelating agents for measuring zinc ions, similar to the ones employed in the
field of calcium biology to measure calcium fluxes [20].
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Figure 3. Cellular zinc transients and their control. Several pathways generate rapid zinc transients
(zinc signals) with biological responses on various time scales. The amplitude of these zinc signals is
about a few nanomolar globally, from picomolar basal “free” zinc ion concentrations, but may be higher
in microdomains. Proteins involved in the control of zinc homeostasis serve as mufflers (ZIPs, ZnTs)
and buffers (MTs) to restore the steady-state. A much slower process (arrow) leads to an overall
change of the zinc-buffering characteristics of the cell, establishing different basal levels of “free” zinc
ion concentrations.
3. The Paradigms for Using Zinc Ions in Information Transfer/Regulation/Communication
A long train of discoveries followed the original observation of a histochemically stainable pool of
zinc ions in the brain over half a century ago [21]. It culminated in the demonstrations that (i) the zinc
ions localize to presynaptic vesicles (boutons) of specialized neurons; (ii) the zinc transporter ZnT3
loads the vesicles with zinc; and (iii) the zinc ions are exocytosed upon electrical stimulation of such
neurons. Subsequently, three types of “zinc signals” in the brain have been defined: the synaptic signal,
described as a type of chemical transmitter/neuromodulator; the transmembrane signal, where the
zinc ions are translocated through the plasma embrane; and the intracellular zinc signal, with release
of zinc ions from a source within cells [22]. All of these signals have now been shown to have
physiological roles, not only in the brain, but importantly, in many other tissues, thus establishing at
least three general pathways for the generation of zinc ion transients.
3.1. Release of Zinc Ions from Cells by Vesicular Exocytosis
Ev ry cell has the capacity to export an excess of zinc. It appears that zinc is sequestered
first in cellular vesicular stores, and that export from the cell occurs only after the capacity of the
stores is exhausted. However, a number of cells, including neurons with glutamatergic/zincergic
synaptic vesicles, have the additional capacity to secrete zinc ions by calcium-dependent exocytosis for
a specific purpose [23,24]. In neurons, in addition to postsynaptic effects, zinc has a presynaptic effect,
re-entering the neuron and affecting phosphorylation signalling via inhibition of protein tyrosine
phosphatases (PTPs) [25,26]. In cells secreting zinc via exocytosis, there is an additional demand for
zinc, as zinc brought into the secretory vesicles can reach relatively high concentrations (about mM) and
needs to be replenished after secretion. High zinc concentrations have a function within the vesicles,
e.g., a structural role together with calcium in the insulin hexamer in the dense granules of β-cells in the
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endocrine pancreas or inhibiting proteases in zymogen granules of acinar cells in the exocrine pancreas.
Zinc ions are co-secreted from these vesicles, and paracrine, autocrine, and even endocrine roles for
the zinc ions [Zn2+]e have been suggested, e.g., in β-cells, in addition to their function in preventing
amyloidosis of the secreted amylin and insulin [27]. For an endocrine effect, proof is lacking that the
secreted cellular zinc increases the rather high total zinc concentration of blood sufficiently, in order
for the liver to detect a zinc signal emanating from the pancreas [28]. It would seem that a specific
complex of zinc needs to carry the information of the endocrine signal. Zinc-secreting cells also include
prostate epithelial cells (zinc in prostate fluid), mammary gland epithelial cells (zinc in milk), intestinal
Paneth cells, cells of the immune system (mast cells, granulocytes, neutrophils), and platelets. It is not
clear whether zinc is the only cargo in any of these exocytotic vesicles. In fact, it is highly unlikely
because secretory vesicles are biochemically quite complex, as shown for the dense granules of β-cells,
which contain more than 300 different proteins [29]. It is also not clear how zinc is made available in
the cytosol, where the concentration of free zinc is only picomolar, for loading the vesicles, and what
the chemical forms of zinc are, in addition to protein-bound zinc in the vesicles.
Zinc in secretory vesicles→ Ca2+-dependent exocytosis→ increase of [Zn2+]e →multiple targets
Another important biological event is the release of zinc ions from fertilized mouse oocytes [30].
These “zinc sparks” are preceded by calcium oscillations after fertilization/chemical-induced activation
of the oocyte. The secreted zinc ions have a role in hardening the zona pellucida (glycoprotein matrix)
to avoid polyspermy—yet another function of the secreted zinc on proteins.
3.2. Intracellular Release of Zinc Ions through Reactive Species Modifying Proteins
This pathway is based on the recognition that zinc coordination environments with thiolate
(cysteine) sulphur, such as in MTs, are redox-active, despite zinc ions being redox-inert in biology.
Oxidation of the sulphur ligand donor controls the dissociation of zinc ions [31]. It was the first
pathway to show a way of releasing zinc intracellularly and increasing the free zinc ion concentrations,
[Zn2+]i, overcoming the paradox of how zinc can be made available when it is bound with such high
affinity to proteins. The list of oxidants is extensive, and includes reducible sulphur and selenium
compounds [32,33]. In addition, reactive species such as nitric oxide, and electrophiles such as
carbonyls react with the sulphur ligand donor [34]. The release of zinc has been shown in many
cellular systems, e.g., nitric oxide signals target MTs and release zinc [35,36], and cell-permeable
disulphides increase the available cellular zinc ion concentration [37]. The majority of investigations
has addressed pathophysiological (oxidative stress releasing zinc), pharmacological (drugs releasing
zinc), and toxicological (toxins releasing zinc) events. The released zinc ions first have a cytoprotective,
and then a cytotoxic effect [38]. Many of the agents investigated react with MTs with concomitant
release of zinc, which then activates MTF-1 to induce gene expression. In this pathway, MT is a signal
transducer, generating zinc signals in response to redox signals. The physiological significance seems
to be that signalling with many growth factors generates reactive species that can then generate cellular
zinc transients [Zn2+]i for the purpose of modulating signal transduction.
Reactive species/redox signalling→MTs→ increase of [Zn2+]i →multiple targets and
MTF-1-dependent gene expression
3.3. Intracellular Release of Zinc Ions through Channels of Vesicular Stores
It was summarized, at the turn of the millennium, that zinc has functions at all levels of cellular
signalling, and that growth factor signalling affects intracellular zinc re-distribution and functions [39].
The underlying idea, though, was that the extracellular zinc taken up by the cell is responsible for the
observed effects.
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A key discovery that expanded the possibilities of zinc as a signalling ion was that cross-linking
of the high affinity immunoglobulin E receptor (Fcε receptor I) in mast cells causes release of zinc ions
intracellularly from the perinuclear area, including the endoplasmic reticulum (ER). The response
was dependent on calcium influx, caused mitogen-activated protein kinase (MAPK)/extracellular
signal-regulated kinase (ERK) activation, and was called a “zinc wave”. While the targets of zinc
were not identified, it demonstrated that zinc serves the role of a second messenger in modulating the
signalling of plasma membrane receptors [40].
Another key observation was that zinc ions are released from an ER store through a specific
pathway that includes the casein kinase 2-mediated phosphorylation and opening of the ZIP7
channel [41]. The released zinc affects phosphorylation signalling, and it appears to do so primarily by
inhibiting PTPs [42].
Growth factor signals→ casein kinase 2 (CK2)→ ZIP7 phosphorylation→ increase of [Zn2+]i →
inhibition of protein tyrosine phosphatases (PTPs) and enhanced phosphorylation signalling
4. Targets of Zinc Signals (Sensors, Effectors, and Stimuli)
Zinc binds to and stimulates a zinc-sensing receptor (ZnR) that triggers intracellular calcium
release [43]. This receptor turned out to be the G-protein coupled receptor GPR39 [44–46],
which activates inositol triphosphate (IP3) signalling and calcium release. What is not resolved,
as yet, is where the zinc signal originates from, i.e., how a zinc signal can occur in a zinc-buffered
extracellular milieu, whether it is part of the exocytotic pathway of zinc ions, and whether it originates
from the same cell or another cell. GPR39 is an orphan receptor, and it is not clear whether or not zinc
is the primary agonist or merely a modulator.
[Zn2+]e → GPR39→ IP3 → increase of [Ca2+]i → phosphorylation signalling
(ERK/protein kinase B (AKT))
With the exception of ZnR/GPR39 and activation of MTF-1, the investigated effects downstream
of the signalling zinc ions are, in most cases, not the zinc-dependent proteins themselves.
Therefore, the direct molecular targets of the signalling zinc ions remain poorly defined. This is
an important missing piece of information that is affecting the wider acceptance of Zn2+ as a second
messenger, and so is the issue in which chemical form zinc ions transmit the signal, in particular,
since a zinc-binding messenger protein, such as the calcium signal transducer calmodulin, has not
been identified. In none of the cases of zinc signalling is the chemical identity of the zinc signal
known. It is an important issue as the bioinorganic chemistry of zinc is quite different from
that of calcium, and the term “free” does not apply in the same way. Any ligand of zinc could
impact the specificity of the zinc signal, and thus, its information content [7]. Links between
signals and effectors (targets) have been established, though. In neuronal zinc signalling, the NMDA
(N-methyl-D-aspartate) receptor, a calcium channel, is a well characterized target. Zinc inhibits this
receptor with nanomolar affinities at a structurally characterized site [47]. In the case of GPR39, calcium
signalling is a downstream event of the zinc signal, too. Calcium signals can also be upstream of
the zinc signal, e.g., when Ca2+/calmodulin activates nitric oxide synthase, and nitric oxide releases
zinc from proteins. The intracellularly released “zinc wave” modulates phosphorylation signalling.
Here, it seems that protein tyrosine phosphatases (PTPs) are targeted. Their inhibition enhances the
phosphorylation signalling, i.e., the effect of kinases. PTPs are not described as metalloproteins, but zinc
inhibits them with picomolar to nanomolar affinities with a specific mechanism that is independent of
their redox modulation [48]. In the case of ZIP7 channel-released zinc, the phosphorylation signal is
upstream and downstream of the zinc signal. There are other targets of zinc transients, and we are far
from having a complete list of them [10]. The zinc signals downstream of redox signals seem to be
a response to redox or carbonyl stress, and are linked to repair and defence pathways, and to initiating
a response that restores the redox balance. PTPs are targets, but there is the potential for a much
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greater number of targets, depending on the intensity of the stress signal, and hence, the amplitudes
of the zinc signal. Here, too, like in calcium and phosphorylation signalling, zinc transients/signals
are upstream and downstream of redox effects, as zinc ions have pro-antioxidant and pro-oxidant
effects, depending on their intracellular concentrations [49]. The observation of both upstream and
downstream effects of zinc ion signals in signal transduction by calcium, redox, and phosphorylation
signalling, suggests that the regulatory function of zinc signals is one of feedforward or feedback on
these pathways and other pathways [50,51]. Zinc inhibition of phosphodiesterases controlling cAMP
and cGMP signalling have been described, expanding this network of zinc regulation even further [39].
It appears that zinc, as the redox-inert metal ion with the highest affinity, is well suited for a regulatory
position higher up in the hierarchy.
It remains crucial to quantitate the amplitudes and duration of zinc signals, and match them
to the affinities of targets of zinc, in order to tease apart the biological significance of the signalling
effects. Proteins targeted by transient zinc signals need to be differentiated from proteins affected
by long-lasting changes in cellular zinc concentrations. In one case, the effect of the signal is readily
reversible, while it will be long-lasting when the cell is brought into a different physiological state.
Importantly, such a transition does not necessarily require a change in total zinc concentrations,
but a change in the zinc buffering capacity, such as an increase or decrease in the concentrations of
MTs. The very high affinity of some PTPs for zinc suggests that they are inhibited tonically, and then
activated [9]. It is not known whether this occurs via a general mechanism, with generation of higher
chelating capacity of the zinc-buffering species, or by specific molecules that bind to PTPs and remove
the inhibitory zinc ion.
5. Genomic Effects and the Roles of Metallothioneins (MTs) and MTF-1 in Buffering and
Muffling Zinc
Zinc signalling and zinc regulation are two different aspects. The discussed pathways of
non-genomic zinc signalling eventually lead to genomic (transcriptional) responses via their effects
on classical signal transduction pathways. These responses are part of zinc regulation. MTF-1 can
sense zinc signals directly and induce gene transcription. More than 1000 genes have cis-acting metal
response elements (MREs), but only 43 were identified as putative MTF-1 targets [52,53]. Among these
targets, about 50% are transcription factors, and 19 are genes involved in development, demonstrating
the role of zinc in developmental programmes as genetic ablation of MTF-1 is embryonically lethal
in the mouse. Other target genes are γ-glutamate-cysteine ligase heavy chain needed for glutathione
biosynthesis, and the zinc exporter ZnT1, and most, but not all MTs. In addition to the constitutively
expressed ZnT1 and MT proteins buffering zinc signals/transients, the induced ZnT1 and MT proteins
can adjust the zinc buffering capacity, and hence, the free zinc ion concentrations (Figure 4). Two effects
are responsible for such adjustments. One is zinc buffering by MTs, and the other is a process called
muffling, which refers to transporting metals into and out of the cytosol, and is a typical component
of biological buffering mechanisms [54]. Knockdown of MTF-1 results in more genes becoming
zinc-responsive and in unmasking repression of transcriptional responses of genes that have a zinc
transcriptional regulatory element (ZTRE). It suggests that MTF-1 is high up in a hierarchy of sensors,
and that its control of the expression of ZnT1 and MTs buffers the transcriptomic response to zinc [55].
A postulated mechanism of how MTF-1 functions is that a 10–50-fold difference in affinity of its zinc
fingers is used for zinc sensing [56]. This direct effect of zinc on gene expression, via the zinc sensor
MTF-1, is in addition to its indirect effects as a structural cofactor in hundreds of transcription factors
with zinc fingers and related motifs.
The biochemistry of both MTF-1 and MTs shows that the control of zinc homeostasis interacts
with numerous other cellular systems. A host of factors induce MT expression, not only with the
purpose of sequestering any surplus of zinc, but also for providing enough metabolically available zinc
for cellular processes. The rapid zinc binding, the mechanisms of releasing zinc, and the affinities of
MTs for zinc match the requirements for controlling cellular zinc. Only now, 60 years after its discovery,
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with an understanding of both the quantitative aspects of zinc metabolism and the complexity of
cellular homeostatic control of zinc, the role of the particular zinc/thiolate cluster chemistry of MTs in
zinc metabolism, believed to be elusive, is becoming evident [15].Int. J. Mol. Sci. 2017, 18, 2285  8 of 12 
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6. Definition of Signalling/Regulation with Regard to Zinc
It was the intent of this short account to introduce the paradigms of zinc signals and zinc signalling
for some of the regulatory roles of zinc. The terms “signals” and “signalling” have been applied to
describe different scenarios where zinc (II) ion transients are detectable. With some ambiguity in the
use of the terms, the credibility of the field will suffer without a clear definition of the role of zinc in
cellular signalling.
First, the terms zinc signals and zinc signalling should be used only where zinc ions participate
as messengers in cellular signalling. The criteria for a second messenger, namely that changes of
a short-lived metabolite—and a mechanism to terminate the response—lead to a rapid alteration
of the activity of (an) enzyme(s), are fulfilled in the above pathways. Of course, with metal ions,
the metabolite itself is not short-lived—the availability of the metal ion controls the signal. As pointed
out in calcium biology, where IP3 is the second messenger that releases calcium from the ER, calcium
is actually the third messenger. This distinction is rarely made, and calcium is generally referred to
as a classical second messenger. In the same line of thought: zinc will be the fourth messenger in
the signalling cascade when the calcium signal is upstream of the zinc signal. The other signalling
functions discussed refer to extracellular zinc ions. Here, Zn2+ is a first messenger, a stimulus like
a hormone binding to a receptor, when it binds to GPR39. For such an action, a zinc signal must be
generated in the extracellular environment which has a buffered steady-state concentration of zinc.
Second, the terms should be reserved for transient physiological signals and not be used for
non-physiological concentrations of zinc that are the result of an imbalance or a breakdown of
homeostatic control. The two situations are part of a spectrum of actions, and can be distinguished
only when it is known that the homeostatic system is unable to cope with the zinc concentrations.
Third, like calcium signals, zinc signals have spatiotemporal characteristics with relatively short
transients. I suggest that the terms “late” zinc signals and signalling should not be used because they
are a consequence of the short-lived zinc transients, and refer to slow transcriptional, or other responses
to zinc. For example, cells adjust to different physiological states requiring a re-programming that may
involve gene expression. Resting, proliferating, differentiating, and apoptotic cells all have a different
basal “free” zinc ion concentration [7].
7. Conclusions
The most important message is that zinc is a major cellular regulatory ion in the series of
biologically redox-inert metal ions Na+, K+, Mg2+, Ca2+, Zn2+, making zinc regulation not a specific
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topic with isolated modes of actions, but a general one in cellular biochemistry/biology. The regulatory
functions are in addition to its roles as a catalytic and structural cofactor in the already impressive
number of zinc metalloproteins. Cellular zinc is controlled by a large network of specific proteins that
interact with virtually all pathways controlling metabolism and cell fate. A most recent example is the
identification of ZIP9 as an androgen receptor that is coupled to G-proteins, and mediates non-classical
responses to androgens [57].
Recent developments show the field of zinc biology to be as important as the fields of iron or
calcium biology. Zinc shares relatively high abundance and cellular concentrations with both. Zinc is
not a trace element, but rather a mineral and major constituent of the cell. While iron biochemistry has
been a forerunner in metallobiochemistry, zinc biochemistry turns out to be an even more pervasive
topic. Zinc has been classified as a type 2 nutrient, such as magnesium, with a general function in
metabolism, as opposed to type 1 nutrients, such as iron with more specific functions [58]. With iron,
it shares the many functions in metalloproteins, and with calcium, it shares the signalling capacity.
Like calcium, genetic and environmental factors that affect homeostatic control can cause zinc disorders
and dysregulation, which are the cause of many diseases [59].
The physicochemical properties that make zinc ideally suited for the wide range of biological
functions have been pointed out repeatedly, and the potential of the field was predicted in a now
classic review published 25 years ago [60]. Likewise, the anticipation that zinc will be the calcium
of the 21st century, in terms of its signalling capacities, seems to be gaining traction [61]. The time
has come for the implications of zinc serving major regulatory functions in the cell to be recognized
outside the relatively small community of zinc biologists.
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PTP protein tyrosine phosphatase
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